B4GALT1 and colorectal carcinoma: The B4GALT1 promoter is more heavily methylated in invasive CRC lesions than in non-invasive CRC lesions [39], and B4GALT1 expression has been suggested as a prognostic biomarker in renal, bladder, and lung cancer [40–42].